Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment options.
Laboratories would literally go dark,” says a medical research insider, if Trump administration cuts to NIH funding go ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback